Literature DB >> 2007414

Hypertension and impotence.

S C Müller1, H el-Damanhoury, J Rüth, T F Lue.   

Abstract

In a group of 472 impotent patients who were evaluated with pharmacologic duplex sonography, 117 patient (24.8%) had a history of hypertension, 26 of them (22.2%) for more than 10 years. Objective data about the changes in pulsation, diameter and blood flow velocity of the penile arteries after papaverine injection and the resulting erectile response allowed indirect assessment of the penile venous function. Varying degrees of impaired arterial function were diagnosed in 85% of the patients. The duration of hypertension had less deteriorating effects on the penile arterial system than second risk factors such as diabetes mellitus (n = 31) or smoking (n = 26). Patients on antihypertensive medication (n = 88, 75.2%) demonstrated a worse arterial response to papaverine than those without medication (n = 29, 24.8%). The best vascular response to papaverine injection was found in patients taking a combination of beta-blockers and vasodilators (n = 6), whereas thiazides either taken alone or in combination (n = 51, 60%) seem to have a deteriorating effect on arterial function. However, the arterial response did not correlate with the ability to achieve 'full erection' after intracavernous papaverine injection. Clinical experience confirms that certain antihypertensive drugs affect not only the blood pressure, but also compliance of the erectile tissue resulting in a functional venous leak. This may impair erectile function as much as arteriosclerotic changes of the vascular system secondary to hypertension.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007414     DOI: 10.1159/000473574

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  12 in total

1.  Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

2.  Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service.

Authors:  A Aversa; A M Isidori; D Gianfrilli; E A Greco; A Graziottin; G Zizzo; A Lenzi; A Fabbri
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 3.  Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs.

Authors:  Rainer Düsing
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire.

Authors:  P E Wändell; B Brorsson
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Impact of frequency of intercourse on erectile dysfunction: a cross-sectional study in Wuhan, China.

Authors:  Zhanting Qin; Binqun Tian; Xinghuan Wang; Tongzu Liu; Jinbing Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

6.  Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men.

Authors:  Arie Roth; Ofra Kalter-Leibovici; Yehuda Kerbis; Ella Tenenbaum-Koren; Juza Chen; Tamar Sobol; Itamar Raz
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

Review 7.  Drug-induced male sexual dysfunction. An update.

Authors:  G B Brock; T F Lue
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

8.  Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Andre B Araujo; Gretchen R Chiu; Raymond C Rosen; John B McKinlay
Journal:  Prev Med       Date:  2009-11-24       Impact factor: 4.018

Review 9.  Erectile dysfunction: symptom or disease?

Authors:  C Foresta; N Caretta; A Aversa; C Bettocchi; G Corona; S Mariani; M Rossato
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

Review 10.  Sexual dysfunction in patients with hypertension: implications for therapy.

Authors:  Carlos M Ferrario; Pavel Levy
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.